{"id":"W2952175842","doi":"10.1097/01.hs9.0000559784.51441.da","title":"PF393 A RANDOMISED JOINT AUSTRALASIAN (ALLG) AND FRENCH (FILO) STUDY OF LENALIDOMIDE CONSOLIDATION IN PATIENTS WITH RESIDUAL CLL AFTER FRONT‐LINE TREATMENT WITH FC/FCR (THE CLL6 TRIAL)","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Nutrasource","funders":"","keywords":"Lenalidomide; Medicine; Minimal residual disease; Fludarabine; Internal medicine; Oncology; Progression-free survival; Cyclophosphamide; Chronic lymphocytic leukemia; Surgery; Leukemia; Chemotherapy; Multiple myeloma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003743651,0.0002891099,0.0008094824,0.00008778187,0.00003848224,0.00002608349,0.00008418081,0.0001031206,0.0007088637],"category_scores_gemma":[0.00006487866,0.0001530435,0.00005294106,0.000197848,0.0001404629,0.00009493089,0.00004808729,0.0001995686,0.00003171978],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002087268,"about_ca_system_score_gemma":0.001548166,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002305055,"about_ca_topic_score_gemma":0.0039255,"domain_scores_codex":[0.9976218,0.0002446075,0.0005858722,0.0004690844,0.0007104538,0.0003681945],"domain_scores_gemma":[0.998613,0.0002146967,0.0002118392,0.0006494832,0.0001723892,0.0001385993],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7629007,0.005375741,0.2187228,0.0003636868,0.0009661145,0.0002240982,0.008820239,0.0001435521,0.000198358,0.000005989738,0.0003166826,0.001962059],"study_design_scores_gemma":[0.9030489,0.02196024,0.07040588,0.0003945002,0.0003390782,0.00001889755,0.002422824,0.0003159278,0.0008085508,0.000006328397,0.00008633892,0.0001924812],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9909625,0.0001260977,0.000005403729,0.0001565205,0.00003611901,0.008061647,0.00001631007,0.00001825482,0.0006171612],"genre_scores_gemma":[0.9969039,0.00001487635,0.000212554,0.00003541799,0.00006279556,0.0004622172,0.00005595831,0.00003916261,0.002213098],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1483169,"threshold_uncertainty_score":0.776156,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01511151638438078,"score_gpt":0.2572424225864546,"score_spread":0.2421309062020738,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}